- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
CTI settles with GE
Litigation involving CTI Molecular Imaging and GE has been settled out of court. The lawsuits were initially brought by GE against CTI Molecular Imaging, its PETNET Solutions radiopharmaceuticals unit, and certain employees of CTI Molecular Imaging to
Litigation involving CTI Molecular Imaging and GE has been settled out of court. The lawsuits were initially brought by GE against CTI Molecular Imaging, its PETNET Solutions radiopharmaceuticals unit, and certain employees of CTI Molecular Imaging to prevent these former GE employees from potentially disclosing or using GE confidential information. The staff had left GE and joined CTI or PETNET before the litigation was initiated. CTI Molecular Imaging announced that the parties worked together to ensure that sufficient safeguards were in place to prevent potential disclosure of GE confidential information and further disputes. CTI Molecular Imaging will incur no charges in connection with the settlement.
Shaping the Future of Radiology in 2025: Trends, Threats, and Opportunities
January 10th 2025How do we respond to challenges with staff recruitment, cybersecurity, and looming hospital takeovers in radiology? This author assesses key trends in radiology and offers key insights to stay competitive in the field.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
Surveillance Breast MRI Associated with Lower Risks of Advanced Second Breast Cancers
January 8th 2025After propensity score matching in a study of over 3,000 women with a personal history of breast cancer, researchers found that surveillance breast MRI facilitated a 59 percent lower risk in advanced presentations of second breast cancers.
